Do antiphospholipid antibodies enhance thromboembolic risk in patients with cancer?
Pol Arch Intern Med
.
2020 Dec 22;130(12):1026-1028.
doi: 10.20452/pamw.15724.
Epub 2020 Dec 22.
Author
Polona Žigon
PMID:
33355433
DOI:
10.20452/pamw.15724
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Antiphospholipid
Female
Humans
Thromboembolism* / etiology
Uterine Neoplasms*
Substances
Antibodies, Antiphospholipid